NCT04007718

Brief Summary

High rates of anxiety and worry has been observed in people with Parkinson's (PwP). Previous research outside of PwP has shown that individuals with anxiety have a habit of interpreting ambiguous information in a negative manner (i.e., interpretation bias), and that it is possible to encourage a more positive interpretation bias through an online training. In the current study, the aim is to test the acceptability and feasibility of an online training program that aims to encourage more positive interpretation bias in high worrying PwP. Participants complete an online baseline assessment, and are then invited to complete ten training sessions over a period of three weeks followed by another assessment and follow-up assessments (at 1 month \& 3 months). Participants are randomized into either the active condition or control condition. Across both conditions, participants will listen to short, everyday scenarios which are ambiguous (could end positively or negatively). In the active condition, a positive ending is given in half of the scenarios. In the other half, participants are instructed to imagine positive endings to ambiguous scenarios. In the control condition, all scenarios end ambiguously and no instructions are given about imagining positive endings. The primary aim of the study is to test the acceptability and feasibility of the online training platform. Participants will complete a feasibility interview after completing the training. Specifically, the acceptability of the following will be tested: i) the online nature of the training (and lack of face-to-face contact); ii) being randomised into one of the two conditions; iii) the number and duration of the assignments; and iv) the text messages/e-mail/phone call reminders to complete the assignments. The feasibility of the online training platform will be judged on the i) rate of recruitment; ii) retention rates during the training; iii) adherence to the study (i.e., number of assignments completed); iv) retention rates at follow-up. The secondary aim is to estimate the effect size of the active condition (vs. control; on worry scores post-training, and at follow-ups) to inform power analyses for a future randomised control trial. It is hypothesised that the training will be acceptable and feasible in a high worrying PwP sample. It is also hypothesised that the training will be effective in reducing worry and improving interpretation bias.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P50-P75 for not_applicable parkinson-disease

Timeline
Completed

Started Jul 2019

Shorter than P25 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 24, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 5, 2019

Completed
10 days until next milestone

Study Start

First participant enrolled

July 15, 2019

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2020

Completed
Last Updated

October 31, 2019

Status Verified

October 1, 2019

Enrollment Period

9 months

First QC Date

June 24, 2019

Last Update Submit

October 30, 2019

Conditions

Outcome Measures

Primary Outcomes (11)

  • Acceptability; rating of online training

    Whether participants accept the online nature of the training (extent of positive feedback compared to negative feedback)

    At approximately 4 weeks (during the feasibility interview)

  • Acceptability; lack of face-to-face contact

    Whether participants accept the lack of face-to-face contact

    At approximately 4 weeks (during the feasibility interview)

  • Acceptability; number of assignments

    Whether participants accept the number of assignments

    At approximately 4 weeks (during the feasibility interview)

  • Acceptability; duration of assignments

    Whether participants accept the duration of assignments

    At approximately 4 weeks (during the feasibility interview)

  • Acceptability; reminders

    Whether participants accept the text messages/e-mail/phone call reminders

    At approximately 4 weeks (during the feasibility interview)

  • Acceptability; randomisation

    Proportion of eligible participants who agree to being randomised to those who do not agree

    Participants are asked during the eligibility call prior to starting the training if they are happy to be randomised. As such, acceptability to be randomised is at baseline.

  • Training feasibility; rate of recruitment

    The feasibility of the training based on the rate of recruitment

    From recruitment start (moment when Parkinson's UK [United Kingdom] advertise the study) till study close (either end of November, 2019, or when the recruitment target is met; approximately 5 months)

  • Training feasibility; retention rates

    The feasibility of the training based on the retention rates during the training

    Duration of study (approximately 5 months)

  • Training feasibility; study adherence

    The feasibility of the training based on the adherence to the study (number of assignments completed)

    Assignments are completed over three weeks, with a possibility of a one week extension for those who have not completed at least 8 in the three weeks.

  • Training feasibility; retention at one-month follow-up

    The feasibility of the training based on the retention rates at follow-up (i.e., number of missing cases or drop outs at the one month follow-up)

    Duration of study (approximately 5 months)

  • Training feasibility; retention at three-month follow-up

    The feasibility of the training based on the retention rates at follow-up (i.e., number of missing cases or drop outs at the three month follow-up)

    Duration of study (approximately 5 months)

Secondary Outcomes (3)

  • Decrease in worry (estimation of effect size); post-training

    Baseline worry scores will be compared to worry scores after the training (assessment 2; completed approximately 3 weeks later)

  • Decrease in worry (estimation of effect size); at one-month follow-up

    Baseline worry scores will be compared to worry scores at the one-month follow-up

  • Decrease in worry (estimation of effect size); at three-months follow-up

    Baseline worry scores will be compared to worry scores at the three-months follow-up

Other Outcomes (2)

  • Improvement in interpretation bias (scrambled sentences task)

    Comparing baseline scores to post-training (assessment 2; completed approximately 3 weeks later) scores

  • Improvement in interpretation bias (recognition test)

    Comparing baseline scores to post-training (assessment 2; completed approximately 3 weeks later) scores

Study Arms (2)

Active

EXPERIMENTAL
Behavioral: Interpretation bias training

Control

SHAM COMPARATOR
Behavioral: Interpretation bias training

Interventions

Active: 50% positive endings to scenarios, 50% generation of positive endings to ambiguous scenarios Control: 100% ambiguous endings to scenarios with no instructions to imagine positive endings

ActiveControl

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with idiopathic Parkinson's Disease
  • can use a computer independently
  • have (correct to) normal hearing
  • scores above 62 on the Penn State Worry Questionnaire

You may not qualify if:

  • Those who have previously taken part in lab-based studies at King's College London where measures of interpretation bias were included.
  • Currently or have recently (past six months) received psychological treatment.
  • If participants are currently taking anti-depressants or anti-anxiety medication, they need to have been stable on the same dose for at least six weeks.
  • Participants who score 2 or higher on the ninth item of the Patient Health Questionnaire-- (measuring suicidal ideation) at screening will be excluded.
  • If individuals do not have regular access to a computer and/or the internet, they will be excluded.
  • Those who can not concentrated on the questions asked during the Modified Telephone Interview for Cognitive Status, or are confused by the questions asked.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

King's College London

London, SE5 8AF, United Kingdom

RECRUITING

MeSH Terms

Conditions

Parkinson DiseaseAnxiety Disorders

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research associate

Study Record Dates

First Submitted

June 24, 2019

First Posted

July 5, 2019

Study Start

July 15, 2019

Primary Completion

March 31, 2020

Study Completion

March 31, 2020

Last Updated

October 31, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Given the small sample size and specific characteristics of the sample - there is increased likeliness of identifying someone who took part. Other researchers can request data - this will be reviewed by the team per request to ensure there is no possibility to identify any individuals.

Locations